Modulation of Type-1 and Type-2 Cannabinoid Receptors by Saffron in a Rat Model of Retinal Neurodegeneration

PLoS One. 2016 Nov 18;11(11):e0166827. doi: 10.1371/journal.pone.0166827. eCollection 2016.

Abstract

Experimental studies demonstrated that saffron (Crocus sativus) given as a dietary supplement counteracts the effects of bright continuous light (BCL) exposure in the albino rat retina, preserving both morphology and function and probably acting as a regulator of programmed cell death [1]. The purpose of this study was to ascertain whether the neuroprotective effect of saffron on rat retina exposed to BCL is associated with a modulation of the endocannabinoid system (ECS). To this aim, we used eight experimental groups of Sprague-Dawley rats, of which six were exposed to BCL for 24 hours. Following retinal function evaluation, retinas were quickly removed for biochemical and morphological analyses. Rats were either saffron-prefed or intravitreally injected with selective type-1 (CB1) or type-2 (CB2) cannabinoid receptor antagonists before BCL. Prefeeding and intravitreally injections were combined in two experimental groups before BCL. BCL exposure led to enhanced gene and protein expression of retinal CB1 and CB2 without affecting the other ECS elements. This effect of BCL on CB1 and CB2 was reversed by saffron treatment. Selective CB1 and CB2 antagonists reduced photoreceptor death, preserved morphology and visual function of retina, and mitigated the outer nuclear layer (ONL) damage due to BCL. Of interest, CB2-dependent neuroprotection was more pronounced than that conferred by CB1. These data suggest that BCL modulates only distinct ECS elements like CB1 and CB2, and that saffron and cannabinoid receptors could share the same mechanism in order to afford retinal protection.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Crocus / chemistry*
  • Dietary Supplements
  • Endocannabinoids / metabolism
  • Gene Expression Regulation / drug effects
  • Light
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / pharmacology*
  • Photoreceptor Cells / drug effects
  • Photoreceptor Cells / metabolism
  • Photoreceptor Cells / radiation effects
  • Plant Extracts / administration & dosage
  • Plant Extracts / pharmacology*
  • Protein Transport
  • Rats
  • Receptor, Cannabinoid, CB1 / genetics
  • Receptor, Cannabinoid, CB1 / metabolism*
  • Receptor, Cannabinoid, CB2 / genetics
  • Receptor, Cannabinoid, CB2 / metabolism*
  • Retina / drug effects*
  • Retina / metabolism*
  • Retina / pathology
  • Retina / radiation effects
  • Retinal Degeneration / drug therapy
  • Retinal Degeneration / genetics
  • Retinal Degeneration / metabolism*
  • Retinal Degeneration / pathology

Substances

  • Endocannabinoids
  • Neuroprotective Agents
  • Plant Extracts
  • Receptor, Cannabinoid, CB1
  • Receptor, Cannabinoid, CB2

Grants and funding

This investigation was supported by Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2010-2011 grant) to MM, to SB and by Mr. Francesco Segafredo, Essse Caffè S.p.A. The company Hortus Novus s.r.l. provided the saffron used in this study. These supporters had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.